Ampicillin Sodium Injection — FDA Drug Shortage

To Be Discontinued — Sandoz Inc.

The FDA lists a drug shortage record for Ampicillin Sodium Injection (injection) from Sandoz Inc. with status To Be Discontinued. The shortage was first posted on 12/08/2025.

Shortage Details

Status
To Be Discontinued
Company
Sandoz Inc.
Package NDC
0781-9404-95
Dosage Form
Injection
Presentation
Ampicillin Sodium, Injection, 1 g (NDC 0781-9404-95)
Initial Posting
12/08/2025
Revised Date